ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

insulin glulisine

Also written as “Insulin Glulisine”, “Insulin glulisine” and “INSULIN GLULISINE”.

Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus, led by 4 companies.

Drug pageInsulin glulisine: every studyAll 65 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Aug 3, 200642 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sanofi380 open or runningphase 4since Aug 3, 2006Sep 20, 2002none ahead
ikfe-CROits history only20 open or runningphase 4since Aug 15, 2011Aug 15, 2011none ahead
Geropharmits history only10 open or runningphase 3since Jul 9, 2025Jul 9, 2025none ahead
Profil Institut für Stoffwechselforschungits history only10 open or runningphase 1since Aug 31, 2009Aug 31, 2009none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Sanofi only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 20 studies since Sep 20, 2002.

  1. Apr 27, 2007Phase 3 study in Diabetes MellitusNCT00467376 · 485 enrolled · China
  2. Jun 20, 2007Phase 4 study in Diabetes Mellitus, Type 1NCT00489190 · 45 enrolled · Kazakhstan
  3. Sep 6, 2007Phase 4 study in Diabetes MellitusNCT00526513 · 188 enrolled · Egypt
  4. Oct 3, 2007Phase 4 study in Diabetes Mellitus, Type 1NCT00539448 · 98 enrolled · Bahrain, Kuwait, Qatar and more
  5. Jan 23, 2008Phase 4 study in Diabetes Mellitus, Type 1NCT00607087 · 289 enrolled · United States, Australia, Austria and more
  6. Apr 29, 2008Phase 3 study in AMINCT00670228 · 34 enrolled · United States, Argentina, Brazil and more
  7. Aug 24, 20092 phase 4 studiesNCT00965549, NCT00964574
  8. Nov 12, 2009Phase 4 study in Diabetes Mellitus, Type 2NCT01013571 · 493 enrolled · Canada
  9. Feb 25, 2010Phase 4 study in Diabetes Mellitus, Type 2NCT01079364 · 52 enrolled · Netherlands
  10. Jul 8, 2010Phase 1 study in Diabetes Mellitus, Type 2NCT01159353 · 37 enrolled · France
  11. Sep 14, 20104 phase 4 studiesNCT01203111, NCT01202474, NCT01204593 and 1 more
  12. Nov 3, 2010Phase 4 study in Diabetes Mellitus, Type 2NCT01234597 · 219 enrolled · Israel
  13. Sep 20, 2016Phase 1 study in Type1 Diabetes MellitusNCT02910518 · 44 enrolled · Germany
  14. Nov 21, 2017Phase 4 study in Diabetes Mellitus, Type 2NCT03359837 · 384 enrolled · China

TargetBeta

INSR →read by rule
“Insulin receptor agonist”ChEMBL 37, by rule

Other programs on INSR

ProgramCompanyFurthest phaseStudies
Insulin GlargineruleSanofiphase 4190
Insulin AspartruleNovo Nordiskphase 4146
insulin degludecruleNovo Nordiskphase 4108
InsulinrulePfizerphase 450
insulin icodecruleNovo Nordiskphase 430
linsitinibruleAstellas Pharmaphase 313
LY3938577Eli Lillyphase 23

Studies

All 38 Sanofi leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT03359837Diabetes Mellitus, Type 2 · China4CompletedJun 29, 2020384
NCT02910518Type1 Diabetes Mellitus · Germany1CompletedMay 3, 201744
NCT01234597Diabetes Mellitus, Type 2 · Israel4CompletedApr 2015219
NCT01212913Diabetes Mellitus, Type 2 · Korea, Republic of4CompletedMay 2012161
NCT01204593Diabetes Mellitus, Type 1 · Algeria, Argentina, Brazil and more4CompletedJan 2013206
NCT01203111Diabetes Mellitus, Type 2 · Algeria, Brazil, Israel and more4CompletedJul 2012207
NCT01202474Diabetes Mellitus, Type 1 · Russian Federation4CompletedOct 2012100
NCT01159353Diabetes Mellitus, Type 2 · France1CompletedApr 200837
NCT01079364Diabetes Mellitus, Type 2 · Netherlands4TerminatedJul 201252
NCT01013571Diabetes Mellitus, Type 2 · Canada4CompletedJan 2012493
NCT00965549Diabetes Mellitus, Type 2 · Australia, United Kingdom4CompletedDec 2012463
NCT00964574Diabetes Mellitus, Type 1 · Belarus4CompletedJul 201068
NCT00670228AMI · United States, Argentina, Brazil and more3TerminatedNov 200934
NCT00607087Diabetes Mellitus, Type 1 · United States, Australia, Austria and more4CompletedJun 2009289
NCT00539448Diabetes Mellitus, Type 1 · Bahrain, Kuwait, Qatar and more4CompletedDec 200898
NCT00526513Diabetes Mellitus · Egypt4CompletedMay 2008188
NCT00489190Diabetes Mellitus, Type 1 · Kazakhstan4Completed45
NCT00467376Diabetes Mellitus · China3CompletedJun 2008485
NCT00397553Diabetes Mellitus, Type 1 · Russian Federation3CompletedDec 2007104
NCT00384085Diabetes Mellitus, Type 2 · United States4CompletedMar 2010588
NCT00368394Diabetes Mellitus, Type 1 · Germany1Completed18
NCT00360698Diabetes Mellitus, Type 2 · United States, Russian Federation, United Kingdom4CompletedAug 2008106
NCT00311077Diabetes Mellitus1CompletedOct 2004
NCT00310297Diabetes Mellitus, Type 21CompletedDec 2004
NCT00297583Diabetes Mellitus, Type 11CompletedMay 2004
NCT00290979Diabetes Mellitus, Type 1 · Japan3Completed250
NCT00290927Diabetes Mellitus, Type 2 · Japan3Completed390
NCT00290043Diabetes Mellitus, Type 11Completed20
NCT00272064Diabetes Mellitus, Type 2 · Italy3CompletedMay 2008352
NCT00272012Diabetes Mellitus, Type 2 · Germany3CompletedSep 2006396
NCT00271284Diabetes Mellitus, Type 1 · France3CompletedSep 200888
NCT00174668Diabetes Mellitus, Type 2 · Australia, Belgium, Czech Republic and more3CompletedNov 2007311
NCT00135941Diabetes Mellitus · United States3Completed582
NCT00135096Diabetes Mellitus, Type 2 · United States3Completed345
NCT00135083Diabetes Mellitus, Type 23Completed347
NCT00135057Diabetes Mellitus, Type 2 · United States3Completed281
NCT00115570Diabetes Mellitus, Type 1 · United States3CompletedNov 2006572
NCT00046150Diabetes Mellitus, Type 1 · France, Germany, Netherlands3Completed59

How it is read

Names in the registry

  • “Insulin Glulisine”, 12 entries
  • “Insulin glulisine”, 11 entries
  • “insulin glulisine”, 8 entries
  • “INSULIN GLULISINE”, 4 entries
  • “INSULIN GLULISINE (HMR1964)”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.